Column-Shipped 211At for Targeted Alpha Therapy: High Radiochemical Conversion in Organotin Astatination via Redox Activation
ACS Organic & Inorganic Au · 02.11.2026
DOI: 10.1021/acsorginorgau.6c00088 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Organic & Inorganic Au, online erschienen am 02.11.2026. Verfasst von Jehan S. Perera und 7 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nuclear Physics, Office of Isotope Research and Development and Production, National Nuclear Security Administration.
Abstract (Originalsprache)
Astatine-211 is a rare heavy halogen radionuclide whose ability to form covalent carbon–astatine bonds confers distinctive chemical behavior, yet its broader application remains limited by tracer-level availability and complex aqueous speciation. Because production is restricted to a small number of specialized cyclotron facilities worldwide, direct on-site access is impractical for most research and clinical centers; accordingly, distribution from centralized production sites via column-based conveyance provides a practical strategy for expanding access to this promising α-emitter for targeted alpha therapy. This study demonstrates that oxidative activation of column-recovered 211At generates a reactive astatine species that enables efficient labeling of aryl-organotin precursors under mild, catalyst-free conditions. Structurally diverse substrates, including chloro-substituted arylstannanes, guanidyl-functionalized benzyl derivatives, and heteroaryl thiophenes, undergo rapid astatination with radiochemical conversions of 83–95%. This work establishes a practical and electronically tunable platform for 211At radiochemistry using column-shipped material, helping extend astatination chemistry beyond specialized cyclotron facilities.
Förderung
- Nuclear Physics
- Office of Isotope Research and Development and Production
- National Nuclear Security Administration
Zitieren
APA
Perera, J. S., Pyles, J. M., Lawrence, C. C., Tabacaru, G. C., Fritz, S. R., McIntosh, L. A., Yennello, S. J., & Burns, J. D. (2026). Column-Shipped 211At for Targeted Alpha Therapy: High Radiochemical Conversion in Organotin Astatination via Redox Activation. ACS Organic & Inorganic Au. https://doi.org/10.1021/acsorginorgau.6c00088
Vancouver
Perera JS, Pyles JM, Lawrence CC, Tabacaru GC, Fritz SR, McIntosh LA, et al. Column-Shipped 211At for Targeted Alpha Therapy: High Radiochemical Conversion in Organotin Astatination via Redox Activation. ACS Organic & Inorganic Au. 2026. doi:10.1021/acsorginorgau.6c00088
BibTeX
@article{Perera2026,
author = {Perera, Jehan S. and Pyles, Jennifer M. and Lawrence, Christine C. and Tabacaru, Gabriel C. and Fritz, Shayden R. and McIntosh, Lauren A. and Yennello, Sherry J. and Burns, Jonathan D.},
title = {Column-Shipped 211At for Targeted Alpha Therapy: High Radiochemical Conversion in Organotin Astatination via Redox Activation},
journal = {ACS Organic & Inorganic Au},
year = {2026},
doi = {10.1021/acsorginorgau.6c00088}
}
EUVIMED